Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.60001 | 59 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.52394 | 59 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.51861 | 59 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.40688 | 57 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.97354 | 66 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.71204 | 61 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.60975 | 59 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.48867 | 58 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.44615 | 57 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.6151 | 61 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.4519 | 57 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.41258 | 57 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.61003 | 60 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.51508 | 59 |